^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

Actinium-225 conjugated to daratumumab

i
Other names: Actinium-225 conjugated to daratumumab
News
Trials
Company:
Actinium
Drug class:
CD38-targeted antibody-drug conjugate, Ionizing radiation emitter
News
Trials